Advertisement
Advertisement

Thermo Fisher to buy diagnostics firm Binding Site for $2.6 billion

By:
Reuters
Updated: Oct 31, 2022, 15:06 UTC

(Reuters) -Thermo Fisher Scientific Inc said on Monday it would buy specialty diagnostics firm the Binding Site Group from a group led by European private equity firm Nordic Capital in an all-cash transaction valued at 2.25 billion pounds ($2.6 billion).

Visit to AstraZeneca/Thermo Fisher, former Novasep, COVID-19 vaccine plant in Belgium

(Reuters) – Thermo Fisher Scientific Inc said on Monday it would buy Binding Site Group from European private equity firm Nordic Capital in an all-cash transaction valued at 2.25 billion pounds ($2.6 billion), boosting its specialty diagnostics business.

Birmingham, U.K.-based Binding Site’s test helps detect and monitor multiple myeloma, a cancer in a type of white blood cell, and is on track to deliver more than $220 million of revenue in 2022, Thermo Fisher said.

Scientific instruments maker Thermo Fisher’s specialty diagnostics portfolio includes equipment for testing allergy and autoimmune diseases and for monitoring transplant-related biomarkers.

Speciality diagnostics business generated revenue of $3.65 billion for the nine months ended Oct. 1, accounting for about 10% of Thermo Fisher’s total revenue during the period.

U.S.-based Thermo Fisher expects the transaction to be completed in the first half of 2023 and boost adjusted earnings per share by 7 cents on the first full-year of ownership.

Thermo Fisher had earlier this year bought recombinant proteins maker PeproTech for about $1.85 billion in cash, after spending about $17.4 billion to buy clinical research services provider PPD last year.

(Reporting by Leroy Leo and Pratik Jain in Bengaluru; Editing by Sriraj Kalluvila)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement